Confirmed speakers

 

Tony Mire-Sluis, Chair – IABS Human Therapeutics Committee

Ben Ahlstrom, Amgen

Lisa Bernstein, Roche-Genentech

Bruno Boulanger, Arlenda

Rick Burdick, Elion Labs

Oana Danila, Roche

Kristi Griffiths, Eli Lilly and Company

Roger Hart, Amgen

Franz Innerbichler, Novartis

Tilanthi Jayawardena, Biogen

Mark Johnson, AbbVie

Ruojia Li, Bristol-Myers Squibb

Areti Manola, Janssen

Daniel Obeng, Sanofi Genzyme

Laura Pack, Seattle Genetics

Jose Ramirez, Amgen

Andrew Rugaiganisa, Pfizer

Tim Schofield, GlaxoSmithKline

Meiyu Shen, FDA

Jyh-Ming Shoung, Janssen

Perceval Sondag, Arlenda

Walter Stroup, University of Nebraska, Lincoln

Mike Walsh, Health Canada

Dan Weese, Amgen

Lixin Xu, FDA

Ryan Yamagata, GlaxoSmithKline

Harry Yang, MedImmune